Clinical Trial Update: A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase II study evaluating the safety and efficacy of SAL003 in combination with atorvastatin for hypercholesterolemia an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Lipitor (atorvastatin)
• SAL003

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Hypercholesterolemia and Mixed Dyslipidemia | Phase 2 | Status: COMPLETED